Rule

S&P Dow Jones Indices proposed updates to its inclusion criteria on March 13, 2026, potentially allowing SpaceX to join the S&P 500 shortly after its anticipated IPO. The revisions aim to accommodate high-valuation tech firms by relaxing profitability thresholds, reflecting SpaceX's $350 billion valuation and Starship milestones. This development could boost SpaceX's liquidity and investor access, signaling Wall Street's embrace of space tech amid AI and satellite growth. Final rules are expected by Q2 2026, with SpaceX IPO targeted for late 2026.

Major updates to the 340B Drug Pricing Program, announced week of March 8-14, introduce new compliance risks and responsibilities for provider organizations. Changes aim to refine eligibility and auditing amid ongoing legal battles. Hospitals must review contracts to avoid penalties. The reforms seek to enhance program integrity while supporting safety-net access to discounted drugs.

The US Commerce Department withdrew a planned rule on Friday that would have required permits for exports of advanced AI chips from companies like Nvidia and AMD to global customers. The abandoned Trump administration proposal aimed to involve case-by-case reviews by the Commerce Department's licensing office, contingent on factors such as government agreements and end-user computing power needs. Commerce officials rejected returning to the prior administration's 'burdensome, overreaching and disastrous' AI diffusion framework. This decision eases restrictions on the semiconductor industry amid ongoing trade tensions.[1][2]

The US Commerce Department withdrew a planned rule on AI chip exports on March 13, 2026, marking another policy reversal by the Trump administration amid shifting trade priorities. The rule had aimed to tighten controls on advanced semiconductor shipments, particularly to adversaries. This decision eases pressures on US chipmakers like Nvidia, potentially boosting exports while maintaining national security reviews. Tech industry groups welcomed the move, citing reduced regulatory burdens for $50 billion in annual chip trade.